Table of Content - Cell Therapy Market

Global cell therapy market is estimated to be valued at USD 2,583.8 Mn in 2024 and is expected to exhibit a CAGR of 9.4% during the forecast period (2024-2031). Global cell therapy market is expected to witness growth substantially over the next decade due to rising prevalence of chronic diseases coupled with increasing geriatric population globally. Cell therapy is an emerging and promising field that works with living cells to repair, replace or regenerate damaged tissues and cells. Advancements in cell culture techniques, associated technologies and regulatory approvals have supported the development of new therapies to treat blood disorders, cancers, autoimmune diseases and others. With significant investments in research and development and growing regulatory approvals, the cell therapy industry is poised to transform healthcare in the near future.

Market Dynamics:

Global cell therapy market growth is driven by factors such as rising prevalence of cancer and other chronic diseases, increase in funds for cell-based research, and advancement of technologies to develop novel therapies. Moreover, growing geriatric population worldwide prone to diseases is expected to boost demand. However, high costs associated with cell therapy development and stringent regulations for new therapies limits the market growth. Emerging economies offer lucrative opportunities for market players due to growing healthcare investments in countries like China, India and Brazil. Continuous research on stem cells and new applications of cell therapy are anticipated to create new avenues over the forecast period.

Key Features of the Study:

This report provides in-depth analysis of the global cell therapy market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global cell therapy market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study Bristol Myers Squibb Company, Amgen Inc., Novartis AG, Gilead Sciences, Inc., Johnson & Johnson Services, Inc., Allogene Therapeutics, Athersys, Inc., Orchard Therapeutics, JW Therapeutics Co., Ltd., Dendreon Pharmaceuticals LLC., Autolus Therapeutics, APAC Biotech, CORESTEM, Inc., BioCardia, Inc., JCR Pharmaceuticals Co., Ltd., Oxford Biomedica, and CASI Pharmaceuticals Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global cell therapy market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell therapy market.

Detailed Segmentation-

By Therapy Type:
- Stem Cells
- T-cells
- Dendritic Cells
- NK-cells
By Indication:
- Oncology
- Cardiology
- Neurology
- Others
By End User:
- Hospitals
- Clinics
- Research Institutes
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Bristol Myers Squibb Company
- Amgen Inc.
- Novartis AG
- Gilead Sciences, Inc.
- Johnson & Johnson Services, Inc.
- Allogene Therapeutics
- Athersys, Inc.
- Orchard Therapeutics
- JW Therapeutics Co., Ltd.
- Dendreon Pharmaceuticals LLC.
- Autolus Therapeutics
- APAC Biotech
- CORESTEM, Inc.
- BioCardia, Inc.
- JCR Pharmaceuticals Co., Ltd.
- Oxford Biomedica
- CASI Pharmaceuticals Inc.

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Therapy Type
  - Market Snapshot, By Indication
  - Market Snapshot, By End User
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Regulatory Scenario
- Technological Advancements
- Manufacturer Revenue
- Acquisitions and Partnerships Scenario
- Product Launches/Approvals
- Fundings and Investments
- PEST Analysis
- Porter’s Analysis
Global Cell Therapy Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the market
Global Cell Therapy Market, By Therapy Type, 2019 – 2031, (USD Mn)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2019 – 2031
  - Segment Trends
- Stem Cells
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- T-cells
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Dendritic Cells
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- NK-cells
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Global Cell Therapy Market, By Indication, 2019 – 2031, (USD Mn)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2019 – 2031
  - Segment Trends
- Oncology
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Cardiology
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Neurology
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Global Cell Therapy Market, By End User, 2019 – 2031, (USD Mn)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2019 – 2031
  - Segment Trends
- Hospitals
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Clinics
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Research Institutes
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Global Cell Therapy Market, By Region, 2019 – 2031, (USD Mn)
- Introduction
  - Market Share Analysis, By Region, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, For Region, 2019–2031
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Mn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Company Profiles
  - Bristol Myers Squibb Company
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Amgen Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Novartis AG
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Gilead Sciences, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Johnson & Johnson Services, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Allogene Therapeutics
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Athersys, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Orchard Therapeutics
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - JW Therapeutics Co., Ltd.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Dendreon Pharmaceuticals LLC.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Autolus Therapeutics
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - APAC Biotech
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - CORESTEM, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - BioCardia, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - JCR Pharmaceuticals Co., Ltd.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Oxford Biomedica
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - CASI Pharmaceuticals Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
    - Financial Performance
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount